Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein-Reference-Cited by-同舟云学术

Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein

Published:2009-12-03 Issue:4 Volume:9 Page:521-526
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Budayr A.A.,Zysset E.,Jenzer A.,Thiébaud D.,Ammann P.,Rizzoli R.,Jaquet-Müller F.,Bonjour J.P.,Gertz B.,Burckhardt P.,Halloran B.P.,Nissenson R.A.,Strewler Gordon J.

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference30 articles.

1. Rationale for the use of bisphosphonates in bone metastases;Kanis;Bone,1991

2. Peptide mediators of hypercalcemia in malignancy;Strewler;Annu Rev Med,1990

3. Increased levels of a parathyroid hormone-like protein in malignancy-associated hypercalcemia;Budayr;Ann Intern Med,1990

4. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer;Burtis;N Engl J Med,1990

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypercalcemia in non-Hodgkin’s lymphoma due to cosecretion of PTHrP and 1,25-dihydroxyvitamin D;Osteoporosis International;2021-07-06

2. Drug and Hormone Effects on Vitamin D Metabolism;Vitamin D;2018

3. Electrolyte Disorders in Cancer Patients;Onconephrology;2015

4. Drug and Hormone Effects on Vitamin D Metabolism;Vitamin D;2011

5. Hypercalcemia of Malignancy with Simultaneous Elevation in Serum Parathyroid Hormone-Related Peptide and 1,25-Dihydroxyvitamin D in a Patient with Metastatic Renal Cell Carcinoma;Endocrine Practice;2009-04